Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.37 NOK 0.74%
Market Cap: 564.1m NOK

Net Margin
Hofseth Biocare ASA

-52.3%
Current
-73%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-52.3%
=
Net Income
-137m
/
Revenue
262.2m

Net Margin Across Competitors

No Stocks Found

Hofseth Biocare ASA
Glance View

Market Cap
563.2m NOK
Industry
Biotechnology

Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. The company is headquartered in Alesund, More Og Romsdal and currently employs 63 full-time employees. The company went IPO on 2011-12-02. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

HBC Intrinsic Value
3.09 NOK
Undervaluation 56%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-52.3%
=
Net Income
-137m
/
Revenue
262.2m
What is the Net Margin of Hofseth Biocare ASA?

Based on Hofseth Biocare ASA's most recent financial statements, the company has Net Margin of -52.3%.

Back to Top